Affibody AB ("Affibody") today announced that the Trial Review Committee (TRC) has recommended to advance the Phase I clinical study with the Radioligand Therapy (RLT) candidate ABY-271 in ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the ...

Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, announces that data on its CD44v6-targeted radiotherapeutic candidate AKIR001 have been published in The Journal ...

A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, ...

The written report is a legal document communicating the Nuclear Medicine Physician’s imaging consultation to the referring physician. High quality reports must contain essential elements as endorsed ...

You'll typically start with classes and labs in biology, chemistry and physics, then start learning about X-Rays, CT scans, radiation safety and how to take care of patients. You’ll be trained to ...